Supplementary IOL

Colin Kerr

Published: Saturday, April 1, 2017

Rayner has announced that a selection of models in their Sulcoflex range of pseudophakic supplementary IOLs have received Chinese Food and Drug Administration (CFDA) approval. “After a four-year registration application – the longest in the history of Rayner – the CFDA has confirmed it’s approval of this selection of Sulcoflex IOLs. This innovation has been successfully implanted for 10 years and we are excited about launching it in a market as important as China,” said Rayner’s Commercial Director Cary Dawes. “China is Rayner’s number one distributor market in terms of size and growth, so to add the Sulcoflex platform to our offering will open up even more growth opportunities,” he said. www.rayner.com

Latest Articles

Addressing Postoperative Visual Complications

Managing aberrations after laser refractive surgery requires a multi-layered approach.

3D Printing Helps Transform Ukrainian Eye Care

The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.

Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation

Emerging Microbial Trends That Could Affect Your Practices

A triptych of challenges paints a concerning picture for ophthalmologists across the globe.

Improving Outcomes with Laser-Assisted Surgery

Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.

Could the Corneal Transplant Pool Increase?

Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.

Matching Premium IOLs to Visual Lifestyles

From monofocal to full-range solutions, each practice needs comprehensive understanding.

Going Dutch on Acanthamoeba Keratitis

A world-first trial suggests a new medication could beat the disease.

Avoiding Intracorneal Ring Segment Complications

Femtosecond lasers are helping improve refractive results with fewer problems.

Fine-Tuning IOLs After Surgery

Lens power adjustment technology is developing quickly.